Research programme: mitochondrial biogenesis inducers - Mitohealth
Latest Information Update: 17 Aug 2016
At a glance
- Originator Mitohealth
- Mechanism of Action Mitochondrial protein stimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Research Metabolic disorders
Most Recent Events
- 14 Aug 2016 Early research in Metabolic disorders in USA (unspecified route)